STARD3 and neoplasm: Tumor heterogeneity regarding STARD3 overexpression in this series was rare (4%, n = 3/112 had a positive and a negative contingent), however a higher percentage of STARD3-positive tumor cells was significantly associated with pCR (p = 0.015, Table 2).